Mingzuo Jiang

2.1k total citations · 1 hit paper
43 papers, 1.5k citations indexed

About

Mingzuo Jiang is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Mingzuo Jiang has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Epidemiology and 13 papers in Cancer Research. Recurrent topics in Mingzuo Jiang's work include Liver Disease Diagnosis and Treatment (8 papers), RNA modifications and cancer (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Mingzuo Jiang is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), RNA modifications and cancer (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Mingzuo Jiang collaborates with scholars based in China, United States and Japan. Mingzuo Jiang's co-authors include Yi Chu, Yongzhan Nie, Jie Liang, Bing Xu, Nan Wu, Kaichun Wu, Daiming Fan, Bing Xu, Yuying Han and Jiayi Cao and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Mingzuo Jiang

41 papers receiving 1.5k citations

Hit Papers

Gasdermin D plays a key role as a pyroptosis executor of ... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingzuo Jiang China 21 1.1k 569 292 263 171 43 1.5k
Chris Zhiyi Zhang China 25 981 0.9× 495 0.9× 157 0.5× 133 0.5× 175 1.0× 43 1.5k
Mi Ran Kang South Korea 17 1.0k 0.9× 448 0.8× 261 0.9× 115 0.4× 133 0.8× 27 1.5k
Dan Chen China 18 873 0.8× 332 0.6× 193 0.7× 229 0.9× 255 1.5× 77 1.5k
Shanshan Wu China 23 1.4k 1.2× 961 1.7× 209 0.7× 206 0.8× 164 1.0× 63 2.1k
Xiao Tan China 20 975 0.9× 440 0.8× 105 0.4× 191 0.7× 315 1.8× 53 1.4k
Yan Xiang China 14 832 0.7× 614 1.1× 158 0.5× 136 0.5× 74 0.4× 31 1.4k
Sanhong Liu China 24 1.0k 0.9× 570 1.0× 108 0.4× 226 0.9× 152 0.9× 60 1.6k
Shuang Shang China 15 1.0k 0.9× 299 0.5× 194 0.7× 205 0.8× 235 1.4× 23 1.6k
Kyoungsub Song United States 24 875 0.8× 660 1.2× 453 1.6× 154 0.6× 60 0.4× 48 1.7k

Countries citing papers authored by Mingzuo Jiang

Since Specialization
Citations

This map shows the geographic impact of Mingzuo Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzuo Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzuo Jiang more than expected).

Fields of papers citing papers by Mingzuo Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingzuo Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzuo Jiang. The network helps show where Mingzuo Jiang may publish in the future.

Co-authorship network of co-authors of Mingzuo Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingzuo Jiang. A scholar is included among the top collaborators of Mingzuo Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzuo Jiang. Mingzuo Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Lu, Shuo Xu, Qiling Zhou, et al.. (2025). HBOT alleviates diet-induced MASH by reprograming gut microbiota and liver metabolism in mice. Free Radical Biology and Medicine. 237. 600–614. 1 indexed citations
3.
Zhao, Tianming, Kang Jiang, Ying Kang, et al.. (2024). O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36. Metabolism. 156. 155914–155914. 20 indexed citations
4.
Luo, Tingting, Tianming Zhao, Chunyan Chen, et al.. (2023). Hepatocyte DDX3X protects against drug-induced acute liver injury via controlling stress granule formation and oxidative stress. Cell Death and Disease. 14(7). 400–400. 17 indexed citations
5.
Han, Yuying, Xiaoliang Gao, Nan Wu, et al.. (2022). Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Cell Death and Disease. 13(8). 742–742. 54 indexed citations
6.
Gao, Xiaoliang, Mingzuo Jiang, Yi Chu, et al.. (2021). ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. Cancer Letters. 524. 42–56. 22 indexed citations
7.
Fang, Cheng, Xin Guo, Dandan Han, et al.. (2020). Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342–3p. Cancer Letters. 477. 107–121. 13 indexed citations
8.
Chu, Yi, Mingzuo Jiang, Nan Wu, et al.. (2020). O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation. Theranostics. 10(21). 9830–9842. 49 indexed citations
9.
Wu, Nan, Mingzuo Jiang, Haiming Liu, et al.. (2020). LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway. Cell Death and Differentiation. 28(1). 219–232. 125 indexed citations
10.
Du, Feng, Xiaowei Li, Weibo Feng, et al.. (2020). SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET. Oncogene. 39(17). 3522–3540. 40 indexed citations
11.
Han, Yuying, Nan Wu, Mingzuo Jiang, et al.. (2019). Long non‐coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL‐1 expression by sponging miR‐29c‐3p in gastric cancer. Cell Proliferation. 52(6). e12678–e12678. 53 indexed citations
12.
Jiang, Mingzuo, Nan Wu, Xi Chen, et al.. (2019). Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. Journal of International Medical Research. 47(4). 1453–1466. 24 indexed citations
13.
Jiang, Mingzuo, Nan Wu, Bing Xu, et al.. (2019). Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis. Theranostics. 9(18). 5359–5373. 120 indexed citations
14.
Su, Song, Zhenzhen Liu, Fang Wang, et al.. (2019). Aplastic anemia associated with Crohn’s disease: a tertiary center retrospective study. Annals of Hematology. 98(9). 2053–2061. 1 indexed citations
15.
Li, Xiaowei, Mingzuo Jiang, Di Chen, et al.. (2018). miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis. Journal of Experimental & Clinical Cancer Research. 37(1). 71–71. 43 indexed citations
16.
Wu, Nan, Yuying Han, Haiming Liu, et al.. (2018). miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway. Biochemical and Biophysical Research Communications. 503(3). 1491–1497. 34 indexed citations
17.
Jiang, Mingzuo, Bing Xu, Xiaowei Li, et al.. (2018). O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit. Oncogene. 38(3). 301–316. 113 indexed citations
18.
Chen, Di, Li Xu, Xiaowei Li, et al.. (2018). Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer. Cell Death and Disease. 9(10). 998–998. 17 indexed citations
19.
Liu, Qiaoyun, Song Zhang, Yubo Ma, et al.. (2017). Effect of fecal microbial transplant on clinical outcomes and life quality in refractory functional constipation. 7(1). 4–8. 1 indexed citations
20.
Xu, Bing, Mingzuo Jiang, Yi Chu, et al.. (2017). Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. Journal of Hepatology. 68(4). 773–782. 336 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026